UPDATE 1-Apricus says FDA declines to approve erectile dysfunction cream

Feb 16 (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream treatment for erectile dysfunction, for the second time in a decade.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.